BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 28552625)

  • 1. The current status and unmet needs in the management of psoriatic arthritis: Viewpoint from physicians in Taiwan.
    Li TH; Liao HT; Huang YF; Shen YC; Chiu YC; Chen WS; Chen MH; Tsai CY; Chang DM
    J Formos Med Assoc; 2018 May; 117(5):404-412. PubMed ID: 28552625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey.
    van de Kerkhof PC; Reich K; Kavanaugh A; Bachelez H; Barker J; Girolomoni G; Langley RG; Paul CF; Puig L; Lebwohl MG
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):2002-10. PubMed ID: 25885420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Singapore Chapter of Rheumatologists consensus statement on the eligibility for government subsidy of biologic disease modifying anti-rheumatic agents for the treatment of psoriatic arthritis.
    Lahiri M; Teng GG; Cheung PP; Suresh E; Chia FL; Lui NL; Koh DR; Koh WH; Leong KP; Lim AYN; Ng SC; Thumboo J; Lau TC; Leong KH
    Int J Rheum Dis; 2017 Oct; 20(10):1527-1540. PubMed ID: 26353916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey.
    Lebwohl MG; Kavanaugh A; Armstrong AW; Van Voorhees AS
    Am J Clin Dermatol; 2016 Feb; 17(1):87-97. PubMed ID: 26718712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment patterns, unmet need, and impact on patient-reported outcomes of psoriatic arthritis in the United States and Europe.
    Gottlieb A; Gratacos J; Dikranian A; van Tubergen A; Fallon L; Emir B; Aikman L; Smith T; Chen L
    Rheumatol Int; 2019 Jan; 39(1):121-130. PubMed ID: 30426237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Clinical Specialty Setting and Geographic Regions on Disease Management in Patients with Psoriatic Arthritis in the United States: A Multicenter Observational Study.
    Mease PJ; Liu C; Siegel E; Richmond H; Wu M; Chen L; Douglas K; Lockshin B
    Am J Clin Dermatol; 2019 Dec; 20(6):873-880. PubMed ID: 31612380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching biologics in the treatment of psoriatic arthritis.
    Merola JF; Lockshin B; Mody EA
    Semin Arthritis Rheum; 2017 Aug; 47(1):29-37. PubMed ID: 28363434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Psoriatic Arthritis: Traditional Disease-Modifying Rheumatic Agents and Targeted Small Molecules.
    Soriano ER
    Rheum Dis Clin North Am; 2015 Nov; 41(4):711-22. PubMed ID: 26476228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment patterns and health care costs for patients with psoriatic arthritis on biologic therapy: a retrospective cohort study.
    Zhu B; Edson-Heredia E; Gatz JL; Guo J; Shuler CL
    Clin Ther; 2013 Sep; 35(9):1376-85. PubMed ID: 23954091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
    Lyu R; Govoni M; Ding Q; Black CM; Kachroo S; Fan T; Ogbonnaya A; Donga P; Hill J; Makin C
    Rheumatol Int; 2016 Jan; 36(1):143-53. PubMed ID: 26314368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LOOP, a cross-sectional, observational study investigating the clinical specialty setting as a determinant of disease management in psoriatic arthritis: Subgroup analysis results from Japan.
    Okada M; Kurimoto S; Ganz F; Boehncke WH
    PLoS One; 2021; 16(1):e0245954. PubMed ID: 33503031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALIGN PsA: Advancing a Multidisciplinary Approach in PsA.
    Baum EW; Schwartzman S
    Semin Cutan Med Surg; 2018 Dec; 37(6S):S125-S134. PubMed ID: 30605493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cross-sectional questionnaire survey involving physicians for the clarification of the diagnosis and current status of therapeutic intervention of psoriatic arthritis in Japan.
    Asahina A; Minami Y; Kameda H
    J Dermatol; 2024 Feb; 51(2):261-270. PubMed ID: 38087804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical remission in rheumatoid arthritis and psoriatic arthritis.
    Lubrano E; Mesina F; Caporali R
    Clin Exp Rheumatol; 2018; 36(5):900-910. PubMed ID: 29600949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating to target in psoriatic arthritis: assessing real-world outcomes and optimising therapeutic strategy for adults with psoriatic arthritis-study protocol for the MONITOR-PsA study, a trials within cohorts study design.
    Rombach I; Tillett W; Jadon D; Tucker L; Watson M; Francis A; Sinomati Y; Eldridge L; Dritsaki M; Dutton SJ; Al-Mossawi H; Gullick N; Thompson B; Coates LC
    Trials; 2021 Mar; 22(1):185. PubMed ID: 33663566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in the Management of Psoriatic Arthritis in Latin America: A Systematic Review.
    Ribeiro AL; Dullius L; Sartori NS; Azeredo-da-Silva A; Kohem CL; Coates L; Monticielo OA; Palominos P
    Clin Ther; 2023 Sep; 45(9):860-867. PubMed ID: 37198042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of Malignancies in a Cohort of Psoriatic Arthritis Patients Taking Traditional Disease Modifying Antirheumatic Drug and Tumor Necrosis Factor Inhibitor Therapy: An Observational Study.
    Costa L; Caso F; Del Puente A; Di Minno MN; Peluso R; Scarpa R
    J Rheumatol; 2016 Dec; 43(12):2149-2154. PubMed ID: 27633825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of psoriatic arthritis among cutaneous psoriasis patients: from pathogenesis to therapy.
    Hoelt P; Confavreux C; Jullien D; Villani AP
    G Ital Dermatol Venereol; 2017 Oct; 152(5):458-473. PubMed ID: 28534601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for psoriatic arthritis management: A joint position paper of the Taiwan Rheumatology Association and the Taiwanese Association for Psoriasis and Skin Immunology.
    Tsai TF; Hsieh TY; Chi CC; Chou CT; Hsieh LF; Chen HH; Hui RC; Lee CH; Liu CH; Liu HC; Yeo KJ; Chen CH; Chen HA; Chen YC; Chen YJ; Chiu HY; Ho JC; Huang YH; Lai PJ; Lee WR; Liao HT; Lin SH; Tseng JC; Wang TS; Wu NL; Yang DH; Tsai WC; Wei JC;
    J Formos Med Assoc; 2021 Mar; 120(3):926-938. PubMed ID: 33012636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term etanercept survival in patients with psoriatic arthritis: a multicenter retrospective analysis in daily clinical practice in Spain.
    Deza G; Notario J; Ferran M; Beltrán E; Almirall M; Alcalá R; Ruiz-Carrascosa JC; Sánchez R; Pérez S; García-Vivar ML; Galíndez E; Mora M; Rodríguez J; Gallardo F
    Rheumatol Int; 2018 Nov; 38(11):2037-2043. PubMed ID: 30143818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.